[ALNY] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -41.32%
YoY- -21.46%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 750,530 264,306 187,633 125,853 70,061 2,069 17,096 87.76%
PBT 150,741 -405,943 -204,236 -252,452 -208,929 -244,837 -122,937 -
Tax 2,988 -23 278 839 -394 445 -3,296 -
NP 147,753 -405,920 -204,514 -253,291 -208,535 -245,282 -122,937 -
Tax Rate -1.98% - - - - - - -
Total Cost 602,777 670,226 392,147 379,144 278,596 247,351 140,033 27.52%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 19.69 -153.58 -109.00 -201.26 -297.65 -11,855.10 -719.10 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS 1.18 -3.32 -1.72 -2.18 -1.92 -2.43 -1.34 -
EPS Diluted 1.15 -3.32 -1.72 -2.18 -1.92 -2.43 -1.34 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.